The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Radioembolization for Unresectable Neuroendocrine Hepatic Metastases Using Resin 90Y-Microspheres: Early Results in 148 Patients
Abstract
PURPOSE: The use of 90Y-microspheres to treat unresectable liver metastases originating from a variety of neuroendocrine tumors was reviewed. MATERIALS AND METHODS: This is a retrospective review from 10 institutions of patients given 90Y-microsphere therapy for neuroendocrine hepatic metastases. Physical, radiographic, biochemical, and clinical factors associated with treatment and response were examined. All patients were followed with laboratory and imaging studies at regular intervals until death, or censured whether other therapy was given after brachytherapy. Toxicities (acute and late) were recorded, and survival of the group determined. RESULTS: A total of 148 patients were treated with 185 separate procedures. The median age was 58 years (26-95 years) at treatment with median performance status of Eastern Cooperative Oncology Group (0). The median activity delivered was 1.14 GBq (0.33-3.30 GBq) with a median of 99% of the planned activity able to be given (38.1%-147.4%). There were no acute or delayed toxicity of Common Terminology Criteria for Adverse Events v3.0 grade 3 in 67% of patients, with fatigue (6.5%) the most common side effect. Imaging response was stable in 22.7%, partial response in 60.5%, complete in 2.7% and progressive disease in 4.9%. No radiation liver failure occurred. The median survival is 70 months. CONCLUSION: Radioembolization with 90Y-microspheres to the whole liver, or lobe with single or multiple fractions are safe and produce high response rates, even with extensive tumor replacement of normal liver and/or heavy pretreatment. The acute and delayed toxicity was very low without a treatment related grade 4 acute event or radiation induced liver disease in this modest-sized cohort. The significant objective response suggests that further investigation of this approach is warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
Current Status of Gastrointestinal Carcinoids
Modlin, I. M., Kidd, M., Latich, I., Zikusoka, M. N., & Shapiro, M. D. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.03.038 · Cited by 848
Salem, R., & Thurston, K. G. (2006) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000233785.75257.9a · Cited by 699
Self-citationKennedy, A., Nag, S., Salem, R., Murthy, R., McEwan, A. J., Nutting, C., Benson, A., Espat, J., Bilbao, J. I., Sharma, R. A., et al. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.11.060 · Cited by 676
Self-citationThe diagnosis and medical management of advanced neuroendocrine tumors.
Kaltsas, G. A., Besser, G. M., & Grossman, A. B. (2004) · Endocrine Reviews · doi:10.1210/er.2003-0014 · Cited by 674 · cited 1×
“Conventional therapies have largely been considered palliative supportive care.(8) However, aggressive local treatments in the liver have demonstrated improvements in both symptomatic control and survival.”
BackgroundHepatic neuroendocrine metastases: does intervention alter outcomes?1
Chamberlain, R. S., Canes, D., Brown, K. T., Saltz, L., Jarnagin, W., Fong, Y., & Blumgart, L. H. (2000) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(00)00222-2 · Cited by 622
Gray, B., Van Hazel, G., Hope, M., Burton, M., Moroz, P., Anderson, J., & Gebski, V. (2001) · Annals of Oncology · doi:10.1023/a:1013569329846 · Cited by 526
Hepatic resection for metastatic neuroendocrine carcinomas
Que, F. G., Nagorney, D. M., Batts, K. P., Linz, L. J., & Kvols, L. K. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80107-x · Cited by 462
Gupta, S., Johnson, M. M., Murthy, R., Ahrar, K., Wallace, M. J., Madoff, D. C., McRae, S. E., Hicks, M. E., Rao, S., Vauthey, J., et al. (2005) · Cancer · doi:10.1002/cncr.21389 · Cited by 433
Self-citationKennedy, A. S., Nutting, C., Coldwell, D., Gaiser, J., & Drachenberg, C. (2004) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2004.09.004 · Cited by 407
Self-citationKennedy, A. S., Coldwell, D., Nutting, C., Murthy, R., Wertman, D. E., Loehr, S. P., Overton, C., Meranze, S., Niedzwiecki, J., & Sailer, S. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.12.051 · Cited by 375
Self-citationIsolated Liver Metastases from Neuroendocrine Tumors: Does Resection Prolong Survival?
Chen, H., Hardacre, J. M., Uzar, A., Cameron, J. L., & Choti, M. A. (1998) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(98)00099-4 · Cited by 371
Sharma, R. A., Hazel, G. A. V., Morgan, B., Berry, D. P., Blanshard, K., Price, D., Bower, G., Shannon, J. A., Gibbs, P., & Steward, W. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.7916 · Cited by 323
Ho, S., Lau, W. Y., Leung, T. W. T., Chan, M., Ngar, Y. K., Johnson, P. J., & Li, A. K. C. (1996) · European Journal of Nuclear Medicine · doi:10.1007/bf01084369 · Cited by 313
The Management of Patients with Advanced Carcinoid Tumors and Islet Cell Carcinomas
Moertel, C. G., Johnson, C. M., McKusick, M. A., Martin, J. K., Nagorney, D. M., Kvols, L. K., Rubin, J., & Kunselman, S. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-4-199402150-00008 · Cited by 292
Ho, S., Lau, W. Y., Leung, T. W. T., Chan, M., Johnson, P. J., & Li, A. K. C. (1997) · European Journal of Nuclear Medicine · doi:10.1007/bf01728766 · Cited by 255
Aggressive surgery for metastatic liver neuroendocrine tumors
Norton, J. A., Warren, R. S., Kelly, M. G., Zuraek, M. B., & Jensen, R. T. (2003) · Surgery · doi:10.1016/j.surg.2003.07.025 · Cited by 255
Lau, W.-Y., Leung, W.-T., Ho, S., Leung, N., Chan, M., Lin, J., Metreweli, C., Johnson, P., & Li, A. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.436 · Cited by 242
Hepatic surgery for metastases from neuroendocrine tumors
Sarmiento, J. M., & Que, F. G. (2003) · Surgical Oncology Clinics of North America · doi:10.1016/s1055-3207(02)00076-5 · Cited by 227
Osborne, D. A., Zervos, E. E., Strosberg, J., Boe, B. A., Malafa, M., Rosemurgy, A. S., Yeatman, T. J., Carey, L., Duhaine, L., & Kvols, L. K. (2006) · Annals of Surgical Oncology · doi:10.1245/aso.2006.03.071 · Cited by 220
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours
Kaltsas, G., Rockall, A., Papadogias, D., Reznek, R., & Grossman, A. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510015 · Cited by 206
Transcatheter chemoembolization of progressive carcinoid liver metastasis.
Therasse, E., Breittmayer, F., Roche, A., De Baere, T., Indushekar, S., Ducreux, M., Lasser, P., Elias, D., & Rougier, P. (1993) · Radiology · doi:10.1148/radiology.189.2.7692465 · Cited by 172
Hepatic Arterial Chemoembolization for Metastatic Neuroendocrine Tumors
Clouse, M. E., Perry, L., Stuart, K., & Stokes, K. R. (1994) · Digestion · doi:10.1159/000201208 · Cited by 167
Ho, A. S., Picus, J., Darcy, M. D., Tan, B., Gould, J. E., Pilgram, T. K., & Brown, D. B. (2007) · American Journal of Roentgenology · doi:10.2214/ajr.06.0933 · Cited by 158
Kress, O., Wagner, H., Wied, M., Klose, K.-J., Arnold, R., & Alfke, H. (2003) · Digestion · doi:10.1159/000074522 · Cited by 150
Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues
Kaltsas, G., Papadogias, D., Makras, P., & Grossman, A. B. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01116 · Cited by 145
Drougas, J. G., Anthony, L. B., Blair, T. K., Lopez, R. R., Wright, J., Chapman, W. C., Webb, L., Mazer, M., Meranze, S. G., & Pinson, C. W. (1998) · The American Journal of Surgery · doi:10.1016/s0002-9610(98)00042-7 · Cited by 135
Neuroendocrine gastrointestinal tumors - A condensed overview of diagnosis and treatment
Öberg, K. (1999) · Annals of Oncology · doi:10.1093/annonc/10.suppl_2.s3 · Cited by 132
Update on the Management of Neuroendocrine Hepatic Metastases
Madoff, D. C., Gupta, S. K., Ahrar, K., Murthy, R., & Yao, J. C. (2006) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000232177.57950.71 · Cited by 129
Self-citationStubbs, R. S., Cannan, R. J., & Mitchell, A. W. (2001) · Journal of Gastrointestinal Surgery · doi:10.1016/s1091-255x(01)80051-2 · Cited by 129
Carcinoid tumors: molecular genetics, tumor biology, and update of diagnosis and treatment
Öberg, K. (2002) · Current Opinion in Oncology · doi:10.1097/00001622-200201000-00008 · Cited by 123
Hepatic Arterial Chemoembolization in the Management of Advanced Digestive Endocrine Tumors
Ruszniewski, P. B., & Malka, D. (2000) · Digestion · doi:10.1159/000051860 · Cited by 119
Management of midgut carcinoids
Åkerström, G., Hellman, P., Hessman, O., & Osmak, L. (2005) · Journal of Surgical Oncology · doi:10.1002/jso.20188 · Cited by 102
Stubbs, R. S., O’Brien, I., & Correia, M. M. (2006) · ANZ Journal of Surgery · doi:10.1111/j.1445-2197.2006.03834.x · Cited by 96
Sxhupak, K. D., & Wallner, K. E. (1991) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(91)90061-8 · Cited by 96
Steel, J. L., Baum, A. E., & Carr, B. I. (2003) · Psycho-Oncology · doi:10.1002/pon.725 · Cited by 86
Carcinoid Tumors: Current Concepts in Diagnosis and Treatment
Öberg, K. (1998) · The Oncologist · doi:10.1634/theoncologist.3-5-339 · Cited by 65
A 40-year analysis of 265 gastric carcinoids.
Modlin, I. M., Sandor, A., Tang, L., Kidd, M. S., & Zelterman, D. (1997) · PubMed · Cited by 36
Zuetenhorst, H. J. M., Taal, B. G., Boot, H., Olmos, R. A. V., & Hoefnagel, C. A. (1999) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199910000-00014 · Cited by 26
Hepatic arterial chemoembolization in the management of advanced digestive endocrine tumours.
Dominguez, S., Denys, A. L., Menu, Y., & Ruszniewski, P. B. (1999) · PubMed · Cited by 17
Cited by
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Ramage, J. K., Ahmed, A., Ardill, J., Bax, N., Breen, D. J., Caplin, M. E., Corrie, P., Davar, J., Davies, A. H., Lewington, V, et al. (2012) · Gut · doi:10.1136/gutjnl-2011-300831 · Cited by 952
Pavel, M., Baudin, E., Couvelard, A., Krenning, E., Öberg, K., Steinmüller, T., Anlauf, M., Wiedenmann, B., & Salazar, R. (2012) · Neuroendocrinology · doi:10.1159/000335597 · Cited by 873
Zaknun, J. J., Bodei, L., Mueller-Brand, J., Pavel, M. E., Baum, R. P., Hörsch, D., O’Dorisio, M. S., O’Dorisiol, T. M., Howe, J. R., Cremonesi, M., et al. (2013) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-012-2330-6 · Cited by 818
Gastroenteropancreatic Neuroendocrine Tumors
Cives, M., & Strosberg, J. R. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21493 · Cited by 586
Metadata
- Authors
- Kennedy, A. S., Dezarn, W. A., McNeillie, P., Coldwell, D., Nutting, C., Carter, D., Murthy, R., Rose, S., Warner, R. R. P., Liu, D., Palmedo, H., Overton, C., Jones, B., & Salem, R.
- Venue
- American Journal of Clinical Oncology
- Published
- 2008-06
- Volume
- 31
- Issue
- 3
- Pages
- 271-279
- ISSN
- 0277-3732 (ISSN-L)
- OpenAlex
- W2069999129
- Cited by
- 424
- References
- 40
- FWCI
- 20.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.